Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan · Delayed Price · Currency is TWD 33.70
-0.35 (-1.03%)
Apr 2, 2026, 1:18 PM CST
Sofiva Genomics Revenue
In the year 2025, Sofiva Genomics had annual revenue of 385.71M TWD, down -14.91%. Sofiva Genomics had revenue of 95.69M in the quarter ending December 31, 2025, a decrease of -7.52%.
Revenue
385.71M
Revenue Growth
-14.91%
P/S Ratio
1.89
Revenue / Employee
n/a
Employees
n/a
Market Cap
727.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 385.71M | -67.61M | -14.91% |
| Dec 31, 2024 | 453.31M | -13.49M | -2.89% |
| Dec 31, 2023 | 466.80M | -28.98M | -5.84% |
| Dec 31, 2022 | 495.78M | -12.64M | -2.49% |
| Dec 31, 2021 | 508.42M | 19.55M | 4.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 20.51B |
| Bora Pharmaceuticals | 19.01B |
| PharmaEssentia | 15.63B |
| Unicon Optical | 747.16M |
| Ttbio | 392.72M |
| BioLASCO Taiwan | 262.66M |
| EBM Technologies | 253.11M |
| Bioray Biotech | 230.06M |